The distribution of restriction endonuclease (RE) sites was compared for 84 herpes simplex virus type 1 (HSV-1) isolates obtained from the ganglia, facial lesions, genital lesions and from brain tissue from herpes encephalitis cases. The isolates came from Canada, the U.K., the U.S.A. and Japan. Out of a total of 224 sites identified, 87 were variable. Three of the 30 most variable sites were at significantly (P < 0-05) different frequencies in groups of isolates from distinct anatomical sites of isolation; one of these, and a further two sites, were at significantly different frequencies in groups from distinct geographical origins. There are at least two inter-related linkage groups. However, most of the site combinations appear to be random. The variability of RE sites in contiguous genome segments, which include both non-coding and coding sequences, show a marked heterogeneity, indicating that some viral gene sequences are more variable than others. The three RE sites at different frequencies in viral groups from distinct anatomical sites of isolation are in two genome segments : map units 27 to 35 and 50 to 57. We infer from the observed associations with anatomical site of viral isolation that part of at least one of these segments may modulate viral virulence in man following infection.
INTRODUCTION
Herpes simplex virus type 1 (HSV-1) may be isolated from herpetic facial lesions , some head sensory ganglia (Bastian et al., 1972; Baringer & Swoveland, 1973; Baringer, 1974; Warren et al., 1978) , brain of herpes encephalitis cases (Longson & Bailey, 1977; Koskiniemi & Vaheri, 1982) , genital regions in a minority of herpes genitalis cases (Peutherer & Smith, 1981 ; Chang, 1977) , and herpetic infections at other anatomical locations (e.g. Buss & Schary3, 1979) . The questions arise whether HSV-1 substrains exist with special predilection for particular anatomical regions and whether there is evidence for geographical substrain clustering. Whilst HSV-1 intra-strain heterogeneity is well established (Heine et al., 1974; Skate et al., 1975; Cassai et al., 1975; Hayward et al., 1975) , data suggesting non-random association of HSV-1 isolate subgroups with either anatomical sites or geographical regions are very limited (Pereira et al., 1976; Chaney et al., 1983) . As strains of HSV-1 differ considerably in pathogenicity for mice (Hill et al., 1975 ; Kiimel et al., 1982) , the possibility cannot be ruled out that there are virus substrain-specific factors involved in herpes encephalitis, in latency and in other herpetic infections (Baringer, 1975; Nahmias et al., 1982) . This can now be subjected to molecular epidemiological analysis.
In principle, ideal data for determining genetic relationships are nucleotide sequences; indeed, nucleotide sequence divergence has been correlated with temporally and spatially distinct groups of influenza virus (Air, 1981; Webster et al., 1982) . This approach is not practicable at present with HSV, but the analysis of the distribution of certain restriction endonuclease (RE) sites (all six-base sequences) in the DNA is feasible. RE cleavage site data can be (Nei & Li, 1979; Ewens et al., 1981) and have been used to investigate genetic relatedness in both viral DNA (Skare et al., 1975; Buchman et al., 1978; Lonsdale et al., 1979; Summers, 1980; Siddiqui et al., 1979; Callan, 1983 ; Heller et al., 1982) and non-viral DNA (Arnheim et al., 0022-1317/83/0000-5723 $02.00 © 1983 SGM s.M.I. CHANEY, K. G. WARREN AND J. H. SUBAK-SHARPE 1980; Kan et al., 1980; Brown, 1980; Antonarakis et al., 1982) because of the relative ease and reliability with which comparative data can be obtained.
In this study we present data from a total of 85 strains of HSV-1, 84 isolated from ganglia (19), facial lesions (28), genital lesions (12) and herpes encephalitis brains (25). The 85th was HSV-1 strain 17, our standard laboratory strain. The isolates were obtained from the U.K., U.S.A., Canada and Japan and the DNA analysed with eight REs in order to determine whether any group differences could be distinguished and to characterize further the naturally occurring RE site variability.
METHODS

HSV-1 isolates and RE analysis.
The anatomical site of isolation (column 1) and geographical origin of viral isolates (column 2) are given in Table 1 . With respect to the encephalitis and facial viruses, the Cambridge isolates were obtained from Dr J. Nagington, Addenbrookes Hospital, the London isolates from Professor J. A. Dudgeon, Hospital for Sick Children, Great Ormond Street, the Bristol isolates from Dr S. K. R. Clarke and Mr A. Freke, Public Health Laboratories, and the Glasgow isolates from Dr G. Urquhart, Ruchhill Hospital. Isolates USA29 and USA30 came from a trigeminal ganglion and the brain from a herpes encephalitis patient respectively and were obtained by Dr D. Lonsdale from Dr J. R. Baringer. The origin of the American and Japanese ganglion isolates is given in Lonsdale et al. (1979 Lonsdale et al. ( , 1980 . The origin of the genital isolates and the Saskatchewan facial isolates was reported by Chaney et al. (1983) , who made earlier restriction enzyme site comparisons; their data covered 53 of the 87 restriction endonuclease sites for these isolates, but the full characterization is included for completeness.
Growth of viral stocks, 32p-labelled viral DNA preparation, restriction endonuclease digestion with BamHI, Kpnl, XhoI, PvuII, Hpal, EcoRI, HindIII and Bgl] I, electrophoresis and construction of comparative RE maps were as previously described (Chaney et al., 1983) .
Restriction endonuclease maps have been published for HSV-1 17, by Wilkie (1976) , Wilkie & Cortini (1976) , Wilkie et al. (1978) and Sanders et al. (1982) .
History of isolates. HSV-1 17 is the standard Glasgow laboratory strain with which the RE-digested DNA autoradiograms of the other 84 were compared. Nineteen isolates were obtained from trigeminal ganglia; of these two were from Japan, eleven from the U.S.A. and six from Edmonton, Canada; 12 isolates were obtained from genital lesions, either from Vancouver or Saskatchewan, Canada; 28 isolates were obtained from facial lesions, 17 from Saskatchewan, Canada and 11 from England; finally, 25 isolates were from herpes encephalitis brains from various locations in Canada and the U.K. Except for two isolates from the same individual [USA29 (ganglion) and USA30 (brain), which proved identical], all the isolates were from different individuals.
Statistics. The index of variability (IV) is defined as the frequency of virus possessing the particular site, multiplied by the frequency of virus lacking that site x 100.
The average IV of each genome segment is obtained by summing the IVs over all the variable sites in that individual segment, and dividing by the total number of variable and non-variable different sites in the segment.
The extent of association (correlation or linkage in coupling or repulsion) between every pair of variable sites was determined. The product moment correlation coefficient calculated on coded values (presence of site = 1, absence of site = 2) was used as a measure of association, rather than one of the more conventional measures (Habalik, 1982) because of the ease of calculation using the BMDP statistics package (Chaney et al., 1983) . (For the 'very variable' sites, this gives a value very similar to the contingency coefficient but tends to underestimate the significance of the association.)
RESULTS
The distribution of RE sites obtained with eight REs recognizing hexanucleotide sequences (BamHI, KpnI, EcoRI, HindlII, BgllI, PvulI, XhoI, HpaI) were determined in 85 independent isolates of HSV-1.
Variable RE sites are tabulated in Table 1 (a to c). The sites progress from the left-hand end (prototype orientation) of the map and are labelled as described in the footnote to Table 1. A total of 87 variable sites (42 very variable and 45 rare, i.e. found or not found in three or fewer isolates) were detected out of a total of 224 identified RE sites. Of the 87 variable sites, 53 (32 very variable, 21 rare) have been described by Chaney et al. (1983) . Twenty-four of the 34 newly described sites have a low IV; however, one of them, KI 1, is the result of redefining the previously defined site, K2 (Chaney et al., 1983) , splitting it into the two sites K2' and K11. Another very variable site, P11, had been missed previously. El  H1  X2  PI2  K8  X3  HP1  B2  Bg2  B3  HP2  HP3  X4  X5  B14  P2  PI  X6  HP10  Bgl  P17  BI2  K2'  KII  HP4  P3  X7  B4  K14  HP8  X8  X9  K3  P5  P4  X20  K7  KI0  B5  B6  E2  K9  E5  P6  XI0  B7  XI5  PII  XI1  XI2  HP5  BII Table 1 lists the individual restriction endonuclease sites found to vary in the 85 HSV-I isolates. In the characterization of every isolate, each such variable RE site is shown as either present (+) or absent (-) or not determined (n). Each site, starting from the left-hand end of the map is labelled by reference to the first letter, or first two letters of the restriction endonuclease used and then, for those sites described in the previous study of Chancy et al. (1983) numbered as before. Site K2 of Chancy et al. (1983) has been redefined as K2' and K 11. The additional variable sites described in the new isolates are also numbered, starting with a number one higher than that used to describe the initial series. K = Kpnl, X = XhoI, E = EcoRI, B = BamHI, H = HindIII, P = PvuII, Hp = HpaI, Bg = BgllI ; IV = the frequency of the presence of a site x the frequency of the absenceof a site × 100. Can = Canada, Van. = Vancouver, Sas. = Saskatoon, Ed. = Edmonton, Cam. = Cambridge, Bri. = Bristol, Gla. = Glasgow, Lon. = London, Nv. Sco. = Nova Scotia, Ont. = Ontario. Fig. 1 (a) shows the distribution of variable RE sites along the HSV-1 genome. The IV is plotted in histogram form against the approximate map position of the site. The frequently variable sites are identified above the histogram; rarely variable sites are indicated by a vertical line only. There are fewer variable sites in the long and short repeated regions, and in the short unique region fewer than in the long unique region. There does not appear to be any gross heterogeneity in the distribution of the variable sites within the long unique region.
IP
The distribution of variable sites along the HSV-1 genome
However, it is known that certain individual polypeptides are coded in identified segments of the HSV-I genome (Marsden et al., 1978; Morse et al., 1978) as shown in Fig. 1 (b) . When the position of the variable sites is compared with the approximate map positions of the HSV segments encoding different polypeptides it is found that there is a marked heterogeneity in the variability of RE sites in different segments. [At present, we cannot relate this to identified coding sequences; one known KpnI site change in the thymidine kinase (TK) gene has been reported (McKnight, 1980; Wagner et al., 1981) ; in most other cases the length of genome into which a particular polypeptide coding gene is known to fall exceeds that required to code for the polypeptide, so that non-coding sequences or sequences coding for other as yet undetected polypeptides may also be included.] The average IV is shown for each segment in the histogram above the diagram of the segmented genome in Fig. 1 (b) .
A Pearson's Chi-squared test (2 × 15, with 14 degrees of freedom) established that the probability of this distribution being due to random sampling from genome segments of equal RE site variability is slight (P < 0.01). The average IV of these genome segments is about 3.2. The segments mu (map units) 6 to 11, mu 11 to 15 and mu 15 to 20 are about twofold more variable than the average, whereas the terminal repeat genome segments mu 0 to 5, 83 to 87, 96 to 100 and the short unique segment mu 87 to 95 are much less variable than average.
The variability of sites
Twenty-three of the sites are different in only one isolate compared with all the rest: sites Bg 1, HP11, B14, P17, B4, HP8, HP5, K4, B13, P14, B9, E4, H5 and PI9 are each present in only one isolate whereas sites Bg2, X5, HP10, B4, X20, E2, B8, X17 and X22 are only absent in one isolate; similarly 16 sites differ in two isolates: P15, B12, HP4, K10, K9, Bll, X14, H3, P18 and P16 are present in only two isolates while BI, PI2, X4, K14, E5 and H2 are absent from only two isolates; and six sites differ in only three isolates: K8, X13 and K 15 are present in only three isolates whereas El, P6 and E3 are only absent from three isolates. These, then, are by our definition the rarely variable sites. All the other sites are very variable, some very much more variable, e.g. H1 which is present in 42 of the isolates and absent in 42.
Group differences
Groups of isolates obtained from different anatomical sites or from different geographical locations were examined for any association with particular variable RE sites. No significant associations were found with the rarely variable sites. Next, every very variable site was checked by Pearson's Chi-squared test. For the geographical comparison, isolates from the U.S.A. (12), Vancouver (11), Britain (25), Saskatchewan (25) and Edmonton (7) were grouped in a 5 × 2 Chisquared test with 4 degrees of freedom. For the comparison of different anatomical sites of isolation, isolates from ganglia (19), genital lesions (12), facial lesions (28) and encephalitis brains (25) were grouped in a 4 × 2 Chi-squared test with 3 degrees of freedom. Table 2 gives the results for the very variable sites present or absent in at least eight of the 85 isolates (that is with IV > 9).
Of these, 30 very variable sites, three (B3, HP3 and P3) differed significantly in their frequencies (P < 0.05, < 0.01, < 0.01), when comparing isolates from different geographical groups and three (P3, B7 and P11) when comparing isolates from different anatomical sites (P < 0-05, < 0.05, < 0-05). One site (P3) was significantly non-random in both the geographical origin and anatomical site tests. (With 60 significance tests performed, only about three significant at P < 0-05 could be expected by chance.)
The most significant association in the anatomical groupings occurs with B7 and P11, two closely proximate (and negatively correlated) sites in the mu 50 to 57 genome segment. For the geographical groupings the most non-random associations occur with sites B3 and HP3 in the mu 15 to 20 genome segment. Table 3 shows the RE site frequencies for these very variable sites and the spatially associated ones in the relevant genome regions. The groups of isolates can be ordered for any particular site by noting the frequency of either 'site state' (+ or -). To get the consensus order for a segment containing several different sites, the 'site states' are chosen for each site so that the order is as far as possible the same. The values in the table are predominantly those for the 'less frequent state' (LFS).
The mu 23 to 35 region of the genome
P3, which maps close to but outwith the TK mRNA (McKnight, 1980) , differs significantly from random expectation (P < 0.05) in the anatomical site comparison. X6, K2 and K 11 are also n, where x is tbe number of isolates having the 'site state' and n is the total number of isolates in the group. situated in this genome segment and P1 maps to the left closely adjacent. The site frequencies (x/n) are given for each LFS (--+ + -) in Table 3 (a). The anatomical groups can be compared by summing their frequencies and the differences between these values can be taken as some measure of the differences between the groups for this segment. This makes no allowance for differences in group size (n).
The frequencies of the LFS of P1, -; X6, -; K2, + ; K 11, + ; P3, -; are given in Table 3 (a). The overall probability that this distribution of frequencies is the result of random sampling is P = 0.05. The mean LFS (--+ + -) is lowest in the 19 ganglion isolates and about three times that in the facial, encephalitis and genital isolates, suggesting that the ganglion isolates differ from the others in this region of the genome.
The mu 50 to 57 genome segment
There are five very variable sites (X10, B7, P11, XI I, X12; LFS + -+ + -) located in the genome segment mu 50 to 57 (Table 3b) . Two of these, B7 and PI 1, have significantly nonrandom distribution (P = < 0.05) in the anatomical groupings of Table 2 . The frequency of four out of five of these 'site states' (XI0, + ; B7, -; PI 1, + ; XI2, -) is lowest in the encephalitis isolates. The ganglion isolates are the most different with the genital and facial isolates intermediate. An estimate that this distribution of sites could be due to random sampling from a population having the average frequencies may be obtained by adding the Chi-squared and degrees of freedom, from Table 2, P < 0.05.
The most favourable location for investigating anatomical group differences appears to be the region bounded by the B7 and P11 sites, approximately mu 52 to 54. Here the 25 encephalitis isolates form the most homogeneous (least variable) group.
The mu 15 to 20 genome region
The sites B3 and HP3 are at significantly non-random frequencies (P < 0.05, <0-01) when comparing isolates from America, Saskatchewan, Vancouver, Edmonton and Britain. In Table 4 gives the correlation coefficient (positive or negative) between every pair of the 30 very variable sites (IV > 9) for those values significant at the 1 ~ level (r > 0-278). Whenever there was no significant correlation between the states of any pair of sites, the entries in the table are left blank. As can be seen, two out of three neighbouring sites show no association. Nine out of 29 neighbours are significantly correlated. The sites HP1 and X3, which map close to each other (mu 14 to 15), show a very high degree of association (r = 0.85), as do B7 and P11 (r = 0.73) which also map close to each other (mu 52 to 54). (B7 and P11 are also at non-random frequencies in the anatomical grouping; Table 2 .)
Association between different variable sites
The highly correlated sites, HPI and X3, are located in the middle of a contiguous cluster of significantly (though weaker) correlated sites, X1, H 1, X3, HP 1, B2 and B3 which are situated at the left-hand end of the genome (Fig. 1) .
The second pair of highly correlated sites B7 and P11, also occur within a correlated cluster, at mu 51 to 67: X10, B7, P 11, X11, P7, P8 and K5. (It is of interest that the site X 12, which occurs in the middle of the cluster is not significantly correlated with any of the remainder of the group.) Both of these clusters (mu 7 to 20 and mu 51 to 67) are correlated with each other, but not to any of the intervening very variable sites.
DISCUSSION
We have identified 224 sites with eight restriction enzymes in the HSV-1 genome: of these, 137 are constant and found present in all isolates, 45 vary rarely and are present or not present in three or fewer isolates, and 42 vary in four or more of the 85 isolates analysed. In addition, we have discovered several interesting relationships in this study. Firstly, when HSV-1 clinical isolates from ganglia, facial lesions, genital lesions and encephalitis brains are grouped according to anatomical site of isolation, these groupings can differ significantly from equality by the frequency distribution of very variable RE sites (IV > 9), in the genome regions mu 23 to 35 and 50 to 57 (Table 3 ). Secondly, isolates from different geographical locations can be distinguished by the frequency of very variable RE sites in the genome segment mu 15 to 20. Thirdly, there are highly significant linkage relationships both in coupling and in repulsion between both closely related and distant RE sites (e.g. X3, HP1, B2 and P7). Fourthly, there is a non-random and unexpected linkage relationship between two clusters of widely separated sites, mu 7 to 20 and mu 51 to 67. Finally, some segments differ in the variability of their RE sites, which suggests heterogeneity in variability of sequence along the HSV genome.
Previous reports of the RE profiles of HSV-1 encephalitis isolates (Hammer et al., 1980; Whitley et al., 1982) have been interpreted as suggesting that there is probably no set of viral substrains that can be related to the production of HSV encephalitis. However, the encephalitis isolates were not compared with independent isolates from other anatomical sites. Whitley et al. (1982) reported three pairs of BamHI digests of HSV-1 isolates from the mouth and brain of three individuals suffering from encephalitis; two pairs are identical in possessing site B7; of the third pair the brain isolate possesses site B7 while the mouth isolate lacks the B7 site (their Fig.  1 ). This is in good agreement with our data (Table 1) where the site B7 is present in all 25 encephalitis isolates but only in 22 of 28 facial isolates, in 13 of 19 ganglion isolates and in 10 of 12 genital isolates. The smallness of our samples in the four different anatomical groups calls for caution in the weight given to the conclusions concerning group differences; these require further independent confirmation by examining these sites in additional isolates. Our analysis focuses attention on two genome regions, mu 23 to 35 and 50 to 57, where the constellation of very variable RE sites appears to be associated with the anatomical sites of original isolation. We interpret this as suggesting that any one host would be more likely at some state to develop a herpetic disorder, particularly encephalitis, if infected with a virus genome possessing the more virulent constellation of RE sites. The report that clinical HSV-1 isolates are probably very mutable, at any rate in the TK gene (Parris & Harrington, 1982) , suggests that mutation of genotypes in vivo prior to or following reactivation could account for the emergence of a more virulent virus in the infected individual (Kaerner et al., 1983) . Clinical isolates of other encephalitic viruses with differing virulence are well known (Trent et al., 1981 ; Shapshak et al., 1982; Harvey & Volkman, 1983 ; Weiner et al., 1980) . Herpetic infections leading to encephalitis are usually sporadic (Hammer et al., 1980) which would be in keeping with a rare virulence constellation of sites having arisen (by mutation or recombination) in an intrinsically less virulent virus. In addition, the host's genetic make-up would be expected to modify the outcome, as in the case of mice infected with HSV (Lopez, 1980; Schr6der et al., 1981 ; Caspary et al., 1980) .
The correlation of four of the sites, HP1, X3, B2 and P7, was noted in the previous publication on the evidence of the genital and some facial isolates only (Chaney et al., 1983) . Our present extended data are in excellent agreement with the previous finding. The six Edmonton ganglion isolates have very strongly correlated sites across both these clusters, i.e. for the sites (X1, HI, X3, HPI, B2, B3) and (X10, B7, P11, X11, P7, P8, K5); these take the form for isolates LW3 and LW6A of +++--+, +-+++--, for LW8 ++ +--+, +-+++-(+); and the mirror image form for isolates LW2 and LWl0 of ---+ + -, -+ ---+ + ; and for LW 11 of -(+) -+ + , + ---(-)+. Interestingly, the one other Edmonton isolate LW9, which is from an encephalitis case, takes the form + + +---, -+ +, reflecting the first cluster of the LW3 group and the second cluster of LWl 1. The unusual linkage relationships could be interpreted formally in terms of polymorphisms, or possibly in terms of phylogenetic divergence on the part of the virus. But it is, at present, difficult to provide a detailed explanation in molecular terms. One could postulate that the very variable DNA sequences have a limited number of ways of interacting efficiently and effectively with other such sites located in distinct parts of the genome. This could be due to coding for polypeptides with domains which interact of necessity with domains of other polypeptides (coded non-contiguously) which then make for particle stability, etc. Alternatively the interactions could be specific DNA-protein interactions or even DNA-DNA interactions, remembering that the DNA in the particle is wound around a protein core in an unknown but presumably specific way. At present we do not know where precisely the very variable RE sites are located, in polypeptide-specifying or transcript-coding DNA, or in non-coding regions, nor whether all the observed differences are due to changes in the same or in different nucleotides of a particular RE site. When more of the HSV DNA sequence is known this aspect will become much clearer. Thus, at present we can only conclude that very definite strong relationships between variable site frequency in particular regions of the genome exist.
Nucleotide sequence relationships and variable RE site data are usually analysed in terms of molecular evolution and phylogenetic relationships between identified genes or gene families or in terms of linkage groups. The appropriate analysis is partly determined by a priori consideration of actual previously identified relationships and partly by the personal views of the investigators. The individual HSV isolates used here are not known to be in any way related to each other. Hence, we had no reason to try to produce some phylogenetic tree or linkage relationship model, and the only rational approach seemed to relate variable site heterogeneities with anatomical or geographical groupings.
We have found that the geographical groupings differ significantly. This suggests differences in the virus genome pools distinguishing HSV-1 in at least some of the five different geographical locations which have been monitored. These particular geographical locations were compared because the isolates were available to us, not because we designed the experiments a priori to study geographical variation. We would expect that more substantial geographical differences would be detected if small static populations from widely different geographical locations were compared. Such a comparison would be of real interest and allow an assessment of the genetic diversity of HSV genomes and its distribution worldwide.
